Biomed Pharmacother 2017 Aug 18;95:55-61. Epub 2017 Aug 18.
Department of Oncology, Chest Hospital of Hebei Province, Shijiazhuang 050041, PR China.
Tumor-infiltrating immune cells are closely associated with clinical outcome. However, immunohistochemistry-based analysis of tumor infiltrates can be misleading as the representative marker of an immune subpopulation might be expressed in other cell types. In this study, based on a metagene approach (known as CIBERSORT) and an online databse, The Cancer Immunome Atlas (https://tcia. Read More